Live Breaking News & Updates on Yashushi Goto

Stay updated with breaking news from Yashushi goto. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Lantern Pharma Receives Regulatory Approval to Expand Harmonic™ Clinical Trial for Non-Small Cell Lung Cancer in Never-Smokers into Japan and Taiwan

Approximately 33% of all non-small cell lung cancer patients in East Asia are never smokers – a growing and unaddressed patient population.

Dr. Yashushi Goto a leading lung cancer. ....

United States , Exchange Commission On , Securities Exchange , American Cancer Society , Translational Lung Cancer Research , Lantern Pharma Inc , National Cancer Center , Lantern Pharma , East Asia , Translational Lung Cancer , Yashushi Goto , East Asian , Lung Cancer , Rev Clin Oncol , Never Smokers , Tyrosine Kinases , Starlight Therapeutics , Securities Act , Securities Exchange Act , Risk Factors , Annual Report , Exchange Commission , Pharma Disclosure Channels , Disseminate Information ,